Close Menu

private financing

The company has used a portion of the new facility to pay back existing debt to the bank, as well as a final payment designated in the parties' earlier loan agreement.

The firm said that the second tranche is part of the financing provided by Ampersand Capital for the $23.5 million acquisition of Cancer Genetics' biopharma business earlier this year.

Last week's SynBioBeta conference was indicative of the high degree of interest in the synthetic bio space from omics research tool vendors.

Ginkgo plans to strategically partner with leading companies in mature markets to create synthetic biology-based spinouts, something it has already done in ag-bio.

The company was originally founded as a spinoff from Korean genomic services provider Macrogen to offer direct-to-consumer genomic rare disease screening tests.

The company was founded by Washington State University scientists to offer molecular breeding and genomic services for cannabis cultivation.

The San Diego-based DNA synthesis firm this week announced $12.2 million in Series A funding, but has plans to expand the round.

The company plans to use the funding to finish developing and commercially launch its HD-Mapping whole-genome electronic mapping platform.

The firm will use the funding to advance its enzymatic DNA synthesis technology, which has applications in life sciences, information storage, synthetic biology, and electronics.

The Swiss company markets the WAVE system, a waveguide interferometry-based instrument for studying molecular interactions in real time.

Pages

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.